Keyphrases
Acetaminophen
14%
Alendronate
15%
Arthritis
12%
Avian Reovirus
17%
Back Pain
16%
Bone Loss
16%
Bone Mineral
11%
Bone Mineral Density
27%
Celecoxib
12%
Change from Baseline
9%
Chronic Back Pain
21%
Chronic Low Back Pain (cLBP)
17%
Chronic Pain
28%
Clinical Trials
22%
Confidence Interval
15%
Cyclooxygenase-2 Inhibitors
17%
Gastrointestinal Events
13%
Hip Osteoarthritis
27%
Keratan Sulfate
9%
Knee
27%
Knee Osteoarthritis
86%
Lumiracoxib
9%
Meta-analysis
10%
Moderate to Severe
12%
Naproxcinod
11%
Naproxen
21%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
35%
Osteoarthritis
94%
Osteoarthritis Pain
26%
Osteoarthritis Treatment
14%
Osteoporosis
12%
Pain Intensity
12%
Pain Patients
12%
Pain Relief
16%
Patient Global Assessment
13%
Placebo
72%
Placebo-controlled
14%
Proximal Tibia
12%
Randomized Clinical Trial
11%
Randomized Controlled Trial
17%
Randomized Placebo-controlled Trial
17%
Rheumatoid Arthritis
17%
Rofecoxib
23%
Spinal Cord Compression
11%
Spinal Cord Injury
28%
Tanezumab
35%
Tolerability
13%
Tramadol
10%
Virus
11%
WOMAC
27%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
6%
Adverse Event
15%
Alendronic Acid
18%
Analgesic Agent
10%
Antiplatelet
6%
Arthritis
13%
Celecoxib
12%
Chronic Pain
12%
Clinical Trial
15%
Clopidogrel
6%
Controlled Clinical Trial
5%
COX-2 Inhibitor
10%
Cyclooxygenase 2
16%
Diseases
7%
Fasinumab
5%
Glucocorticoid
10%
Hip Osteoarthritis
9%
Ibuprofen
5%
Inflammatory Arthritis
26%
Knee Osteoarthritis
25%
Low Back Pain
7%
Lumiracoxib
9%
Naproxcinod
13%
Naproxen
19%
Nitric Oxide
8%
Non-Steroidal Anti-Inflammatory Drug
35%
Omeprazole
5%
Osteoarthritis
100%
Paracetamol
14%
Parathyroid hormone[1-34]
5%
Physical Disease by Body Function
5%
Placebo
76%
Prostaglandin Synthase
6%
Proton Pump Inhibitor
5%
Randomized Clinical Trial
6%
Randomized Controlled Trial
11%
Rheumatoid Arthritis
26%
Rofecoxib
22%
Spinal Cord Injury
14%
Spine Fracture
5%
Tanezumab
26%
Tolerability
13%
Tramadol
9%
Medicine and Dentistry
Adverse Event
6%
Alendronic Acid
5%
Analgesia
7%
Arthritis
6%
Bone Density
20%
Bone Mineral
13%
Chronic Pain
8%
Clinical Trial
11%
Cross Sectional Study
6%
Cyclooxygenase 2
5%
Cyclooxygenase 2 Inhibitor
5%
Diseases
7%
Finite Element Analysis
8%
Hip Osteoarthritis
7%
Knee Osteoarthritis
27%
Low Back Pain
9%
Magnetic Resonance Imaging
7%
Naproxcinod
8%
Naproxen
11%
Nonsteroid Antiinflammatory Agent
17%
Osteoarthritis
73%
Osteolysis
9%
Osteoporosis
7%
Placebo
38%
Primary Health Care
6%
Proximal Tibia
9%
Quantitative Computed Tomography
6%
Randomized Clinical Trial
8%
Randomized Controlled Trial
11%
Rheumatology
5%
Spinal Cord Injury
30%
Tanezumab
21%
Tramadol
6%
Treatment of Pain
6%
Western Ontario and McMaster Universities Osteoarthritis Index
16%